Status:
UNKNOWN
Reduction of Exit Site Infection in Peritoneal Dialysis Patients
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Peritoneal Dialysis Catheter Infection
Eligibility:
All Genders
18-99 years
Brief Summary
In peritoneal dialysis patients, the presence of the catheter presents a risk of infection - exit site infection, tunnel infection or peritonitis. In our dialysis unit, we noticed a rise in exit-site ...
Detailed Description
Peritoneal dialysis is a method for renal replacement therapy that uses the peritoneal membrane for exchange of fluids and dissolved substance . A catheter is surgically inserted with one end in the a...
Eligibility Criteria
Inclusion
- peritoneal dialysis patients capable to sign an informed consent or have an official guardian
Exclusion
- patient's refusal
Key Trial Info
Start Date :
May 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03798171
Start Date
May 15 2018
End Date
May 15 2021
Last Update
January 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Sourasky Medical Canter
Tel Aviv, Israel